Subarachnoid haemorrhage involves bleeding in the subarachnoid space, where the cerebrospinal fluid is located, between the pia mater and the arachnoid membrane.
Subarachnoid haemorrhage is particularly associated with family history, cocaine use, sickle cell anaemia, connective tissue disorders such as Marfan syndrome or Ehlers-Danlos syndrome, neurofibromatosis, autosomal dominant polycystic kidney disease, and others.
Hydrocephalus refers to increased cerebrospinal fluid, causing expansion of the ventricles, and can be treated with lumbar puncture, external ventricular drain, or ventriculoperitoneal (VP) shunt.
Nimodipine is a calcium channel blocker used to prevent vasospasm, a common complication following a subarachnoid haemorrhage, resulting in brain ischaemia.
With a subarachnoid haemorrhage, a CSF sample will show a raised red cell count, xanthochromia (a yellow colour to the CSF caused by bilirubin), and hypertonic pressure.
The NICE guidelines (2022) recommend waiting at least 12 hours after the symptoms start before performing a lumbar puncture, as it takes time for the bilirubin to accumulate in the cerebrospinal fluid (CSF).
Neck stiffness, photophobia, vomiting, and neurological symptoms such as visual changes, dysphasia, focal weakness, seizures, and reduced consciousness are common features of subarachnoid haemorrhage.